Researchers from Hartford Hospital and the University of Connecticut, USA, indicate that implantable cardioverter defibrillators are more effective in men than in women.
 |
| Implantable Cardioverter Defibrillator (Photo: VNN) |
Researchers from Hartford Hospital in Connecticut and the University of Connecticut, USA, report that implantable cardioverter defibrillators are designed to help patients at risk of prolonged arrhythmias return to normal heart rhythm through electrical shocks, showing greater effectiveness in men than in women.
They conducted tests on five patients requiring implantable cardioverter defibrillators and found that the device reduced the risk of life-threatening cardiac arrest by 24% in men and 12% in women.
Nickole Henyan, the lead researcher and a pharmacist at Hartford Hospital, stated that it is currently inexplicable why men benefit more from the device compared to women.
She mentioned that this finding was presented at a cardiovascular meeting by the American College of Cardiology, emphasizing the need for further research to confirm this issue.
This is not an isolated finding; all other studies have yielded similar differing results.
Ngoc Huyen
